Non-invasive Point-Of-Care Hemoglobin Testing In An Obstetric Population

RecruitingOBSERVATIONAL
Enrollment

125

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

August 31, 2026

Conditions
Pregnancy Anemia
Interventions
DEVICE

Masimo RAD 67

This is an observational study of a non-invasive hemoglobin measurement device in a pregnant patient population. The current standard of care for anemia screening during pregnancy involves performing invasive venipuncture at two separate visits throughout the course of the pregnancy. The purpose of this research study is to compare the device performance with the gold standard hemoglobin measurement (venipuncture). The research team will use the Masimo Rad-67 handheld co-oximeter which has a reusable finger-tip sensor that enables spot-check monitoring measurements of both oxygen saturation and non-invasive hemoglobin measurement. At the time of a blood draw, the research team will place the pulse oximeter on the participant's finger. The devices requires 1-3 minutes for an accurate measurement. After the measurement is complete, the participant will be asked 2 questions on their satisfaction and comfortability with the device and 1 question regarding their skin tone.

Trial Locations (1)

02115

RECRUITING

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Beth Israel Deaconess Medical Center

OTHER